Who makes Buckberg Cardi-Braun?

Buckberg Cardi-Braun is developed by Lourdes Montero Cruces.

What development phase is Buckberg Cardi-Braun in?

Buckberg Cardi-Braun is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Buckberg Cardi-Braun

Lourdes Montero Cruces · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	Buckberg Cardi-Braun
Also known as	Buckberg Cardi-Braun cardioplegia solution. ATC: B05X A16.
Sponsor	Lourdes Montero Cruces
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Evaluation of Clinical Impact of the Type of Cardioplegia Used in the Patient Undergoing Major Cardiac Surgery. (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Buckberg Cardi-Braun CI brief — competitive landscape report
Buckberg Cardi-Braun updates RSS · CI watch RSS
Lourdes Montero Cruces portfolio CI